16. Tabellenverzeichnis – Thyroid Cancer

Version 1.2 · September 2026 · AWMF 031-056OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Participating professional associations and organizations

Schema der Evidenzbewertung nach GRADE

Schema der Empfehlungsgraduierung

Festlegungen hinsichtlich der Konsensstärke

Distribution of the histological subtypes of thyroid carcinoma

Nomenclature of the echogenicity of thyroid nodules

B-mode individual criteria for the assessment of thyroid nodules

Important aspects of structured sonographic documentation of cervical lymph nodes

B-mode criteria for differentiating normal, indeterminate and malignant lymph nodes

Comparison of the 4th and 5th editions of the WHO classification of common thyroid neoplasms of the follicular epithelial cells

Comparison of the histomorphological criteria for the diagnosis of PDTC and DHGTC. Convoluted nuclei are an additional criterion for PDTC according to the Turin criteria. In practice, however, these are a rather uncertain criterion due to the high interobserver variability

TNM classification of thyroid carcinomas according to the 8th edition of the UICC with proposals for the addition of prognostically relevant criteria such as minimal extrathyroidal spread of the primary tumor and extracapsular spread of lymph node metastases

Comparison of different diagnostic systems for thyroid cytology

Classification of the risk classes for papillary and follicular thyroid carcinomas with regard to the risk of recurrence. The percentages are averaged values from the literature; the individual risk of recurrence may differ.

Advantages and disadvantages of radioiodine therapy

The table shows the range usually depending on the risk of the therapy activities used.

Risk groups after RIT and a follow-up period of 2 years

Recommended TSH target ranges in the period after inital therapy until response evaluation after 6 months

Recommended TSH target ranges according to the response after inital response evaluation after 6-12 months

Histomorphologic criteria for the diagnosis of high-grade MTC according to the 5th edition of the WHO classification. A high-grade MTC is to be diagnosed if at least one of the three characteristics is positive.

Risk stratification and management of patients with MEN2 depending on the pathogenic RET variant